WHO ICTRP trial
A randomized, double blind, placebo-controlled, multicenter trial for Qi Xue…
ChiCTR1800016338 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800016338 |
|---|---|
| Public title | A randomized, double blind, placebo-controlled, multicenter trial for Qi Xue Kang oral liquid in the treatment of patients with Qi deficiency and blood stasis syndrome of prolonged menstruation and oligooligarchy |
| Scientific title | A randomized, double blind, placebo-controlled, multicenter trial for Qi Xue Kang oral liquid in the treatment of patients with Qi deficiency and blood stasis syndrome of prolonged menstruation and oligooligarchy |
| Primary sponsor | Beijing Chinese Medicine Hospital affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Prolonged menstruation and menopausal patients with Qi deficiency and blood stasis syndrome |
| Interventions | experimental group:Oral liquid Qi Xue Kang oral liquid;control group:Oral placebo |
| Registration date | May 25, 2018 |
| Target size | experimental group:72;control group:72 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: